Stay on the Sidelines as the Future Looks Potentially Bleak for Teva Stock
Teva (NYSE:TEVA) may be up over 60% from its 52-week low, but Teva stock is not out of the woods yet in terms of its headwinds. Source: JHVEPhoto / Shutterstock.com High debt, its exposure to the opioid crisis, as well as its current price-fixing scandal, offer investors a cocktail of risk. Certainly, the market has priced these risks into shares.
News story posted on 2020-01-05T00:59:00.0000000Z
